Clarivate (NYSE:CLVT) Share Price Crosses Below 200 Day Moving Average - What's Next?

Clarivate logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Clarivate shares slipped below their 200-day moving average of $2.18, reaching an intraday low of $2.07 before last trading at $2.165.
  • Analyst sentiment is cautious: the consensus rating is “Reduce,” with one Buy, five Hold, and three Sell ratings and an average price target of $2.65.
  • Quarterly EPS of $0.21 beat the $0.18 consensus estimate, but revenue of $481.6 million fell short of forecasts and declined 22.7% year over year.
  • Interested in Clarivate? Here are five stocks we like better.

Shares of Clarivate PLC (NYSE:CLVT - Get Free Report) crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $2.18 and traded as low as $2.07. Clarivate shares last traded at $2.1650, with a volume of 3,951,273 shares trading hands.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CLVT. Weiss Ratings reissued a "sell (e+)" rating on shares of Clarivate in a research note on Monday, September 21st. William Blair lowered Clarivate to a "market perform" rating in a research report on Thursday, October 15th. Stifel Nicolaus reduced their target price on Clarivate from $6.00 to $5.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Morgan Stanley started coverage on Clarivate in a research report on Friday, October 30th. They issued an "underweight" rating and a $1.50 price target for the company. Finally, Barclays dropped their price target on Clarivate from $2.50 to $2.00 and set an "underweight" rating on the stock in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Reduce" and a consensus target price of $2.65.

Check Out Our Latest Stock Analysis on Clarivate

Clarivate Stock Down 1.1%

The stock has a market cap of $1.39 billion, a price-to-earnings ratio of -3.55 and a beta of 1.38. The business has a fifty day moving average of $1.86 and a 200 day moving average of $2.18. The company has a debt-to-equity ratio of 0.92, a current ratio of 0.88 and a quick ratio of 0.88.

Clarivate (NYSE:CLVT - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.18 by $0.03. Clarivate had a negative net margin of 17.02% and a positive return on equity of 9.84%. The company had revenue of $481.60 million during the quarter, compared to the consensus estimate of $566.77 million. During the same period in the previous year, the firm posted $0.18 earnings per share. The company's revenue for the quarter was down 22.7% compared to the same quarter last year. On average, equities analysts predict that Clarivate PLC will post 0.67 earnings per share for the current year.

Hedge Funds Weigh In On Clarivate

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FreeGulliver LLC bought a new stake in shares of Clarivate in the 1st quarter valued at approximately $30,000. Headlands Technologies LLC acquired a new position in shares of Clarivate in the 3rd quarter worth approximately $30,000. Commonwealth Equity Services LLC bought a new position in shares of Clarivate during the 3rd quarter worth approximately $30,000. Principal Financial Group Inc. bought a new position in shares of Clarivate during the 1st quarter worth approximately $32,000. Finally, Parallel Advisors LLC boosted its stake in Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company's stock valued at $35,000 after buying an additional 6,687 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company's stock.

About Clarivate

(Get Free Report)

Clarivate provides information, analytics and workflow tools to customers in academia and government, life sciences and healthcare, and intellectual property. Its services help organizations find and analyze research, assess scientific and commercial developments, and manage patents, trademarks and other intellectual property. Its products include Web of Science and ProQuest research resources, Cortellis life sciences intelligence, and intellectual property databases and services such as Derwent.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clarivate Right Now?

Before you consider Clarivate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.

While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines